Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for severe alopecia areata are unsatisfactory, highlighting the need for better options.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Rituximab can cause skin issues, but baricitinib may help improve them.

Homeopathic and biochemic treatments led to hair regrowth and improved confidence in a man with hair loss.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

These gene variations are not linked to alopecia areata in Egyptians.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

There is no significant link between alopecia areata and the PON1 enzyme polymorphisms studied.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Higher levels of certain nerve-related proteins are linked to hair loss in women with scalp pain.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

The Epilight Hair Removal System is effective for temporary hair removal with few side effects, but more research is needed to confirm its safety and long-term results.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Surgical methods like suction blister grafting and split-thickness skin grafting are highly successful for vitiligo repigmentation, but choosing the right patients is crucial for success.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Various treatments exist for hair loss, but more research is needed for better options.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Baricitinib effectively regrows hair in severe alopecia areata cases.